Effectiveness and safety of toripalimab, camrelizumab and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients (Retraction of 10.1111/BCP.14452, 2020)

Effectiveness and safety of toripalimab, camrelizumab and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients (Retraction of 10.1111/BCP.14452, 2020)

The above article from British Journal of Clinical Pharmacology, published online on July 5, 2020 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn by agreement among the authors and John Wiley & Sons Ltd on behalf of the British Pharmacology Society. The withdrawal has...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of clinical pharmacology 2020-10, Vol.86 (10), p.2102-2102
Hauptverfasser: Yuan, Guosheng, Hu, Xiaoyun, Li, Qi, Dai, Wencong, Cheng, Xiao, Ying, Pengfei, Yu, Wenxuan, Guo, Yabing, Chen, Mian, Chen, Jinzhang
Format: Artikel
Sprache:eng
Schlagworte:
Life Sciences & Biomedicine
Pharmacology & Pharmacy
Science & Technology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The above article from British Journal of Clinical Pharmacology, published online on July 5, 2020 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn by agreement among the authors and John Wiley & Sons Ltd on behalf of the British Pharmacology Society. The withdrawal has been agreed in accordance with the authors' decision to revise their study providing the latest data.
ISSN:0306-5251
1365-2125